This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Pliant Therapeutics has discontinued a phase 2b/3 trial after recording at least...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
The acquisition sets up the company to potentially compete against Medtronic and...
The company is handing back the tumor candidate it snapped up in 2021 after init...
Neumora halted one trial of its depression drug navacaprant and paused another p...
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...
Lexicon Pharmaceuticals is yet again defending a mixed set of data on its non-op...
Frazier Life Sciences has launched Callio Therapeutics with $187 million in seri...
Takeda’s $300 million bet on Protagonist Therapeutics’ hematology asset a year a...
Novo Nordisk has forged a deal with Gensaic, agreeing to pay up to $354 million ...
AbbVie is paying $350 million to join the obesity race. The outlay, plus up to $...
Oqory’s planned reverse merger with fellow antibody-drug conjugate company Vince...
With Sunday’s Academy Awards ceremony in the rearview mirror, GSK is looking ahe...
The Department of Health and Human Services is reevaluating a $590 million contr...
Vir Biotechnology may be pushing ahead with its combination therapy in hepatitis...
ElevateBio is seeking out partnerships for its lead gene therapy after the const...
ElevateBio is seeking out partnerships for its lead gene therapy after the const...
The cryoablation devicemaker Adagio Medical has opted to pause the European laun...
The molecular glue wave that first began years ago is still swelling, with Eli L...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
Praxis Precision Medicines has been blindsided by a recommendation to stop a pha...
For a while, special purpose acquisition companies were biotech’s hot ticket to ...
This week on "The Top Line," we hear from Steven McCarroll, Ph.D., whose researc...
Gene therapy maker bluebird bio’s 15-year flight has landed in the nest of priva...